ATE294593T1 - Inclusion-komplex von beta-cyclodextrin mit diclofenac - Google Patents

Inclusion-komplex von beta-cyclodextrin mit diclofenac

Info

Publication number
ATE294593T1
ATE294593T1 AT94307380T AT94307380T ATE294593T1 AT E294593 T1 ATE294593 T1 AT E294593T1 AT 94307380 T AT94307380 T AT 94307380T AT 94307380 T AT94307380 T AT 94307380T AT E294593 T1 ATE294593 T1 AT E294593T1
Authority
AT
Austria
Prior art keywords
diclofenac
cyclodextrin
inclusion complex
beta
molecule
Prior art date
Application number
AT94307380T
Other languages
English (en)
Inventor
Vivienne Jean Griffith
Luigi Renzo Nassimbeni
Douglas George M Nicholson
Mark David Bodley
Mino Rodolfo Caira
Lueta Ann Glintenkamp
Lawrence John Penkler
Oudtshoorn Michael Coenraa Van
Original Assignee
Shimoda Biotech Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shimoda Biotech Pty Ltd filed Critical Shimoda Biotech Pty Ltd
Application granted granted Critical
Publication of ATE294593T1 publication Critical patent/ATE294593T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nanotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT94307380T 1993-10-08 1994-10-07 Inclusion-komplex von beta-cyclodextrin mit diclofenac ATE294593T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA937480 1993-10-08

Publications (1)

Publication Number Publication Date
ATE294593T1 true ATE294593T1 (de) 2005-05-15

Family

ID=66767030

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94307380T ATE294593T1 (de) 1993-10-08 1994-10-07 Inclusion-komplex von beta-cyclodextrin mit diclofenac

Country Status (12)

Country Link
US (1) US5674854A (de)
EP (1) EP0647451B1 (de)
JP (1) JPH07196484A (de)
KR (1) KR950010910A (de)
CN (1) CN1161115C (de)
AT (1) ATE294593T1 (de)
AU (1) AU682887B2 (de)
CA (1) CA2133885C (de)
DE (1) DE69434356T2 (de)
ES (1) ES2240960T3 (de)
IL (1) IL111184A (de)
ZA (1) ZA948078B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2735136B1 (fr) * 1995-06-08 1997-08-14 Roquette Freres Composition pulverulente d'hydroxypropyl-betacyclodextrine et son procede de preparation.
HUP9600758A2 (en) * 1996-03-27 1998-03-02 Cyclolab Ciklodextrin Kutato F Diclofenac composition of diminished gastrointestinal irritation and enhanced biological resorption
US6984632B1 (en) * 1999-07-01 2006-01-10 Italfarmaco S.P.A. Complexes of paroxetine, with cyclodextrins or cyclodextrin derivatives
US7122376B2 (en) * 2001-11-01 2006-10-17 Facet Analytical Services And Technology, Llc Calibration standards, methods, and kits for water determination
US7049146B2 (en) 2000-11-14 2006-05-23 Facet Analytical Services And Technology, Llc Calibration standards, methods, and kits for water determination
JP2005298338A (ja) * 2002-02-27 2005-10-27 Eisai Co Ltd 速崩壊性圧縮成形製剤
KR100473716B1 (ko) * 2002-03-27 2005-03-08 주식회사 참 존 7-디하이드로콜레스테롤 및 사이클로덱스트린의 포접복합체, 이를 포함하는 화장료 조성물 및7-디하이드로콜레스테롤의 안정화방법
AU2003270727A1 (en) * 2002-09-17 2004-04-08 Luna Innovations, Inc. Remote temperature sensing of small volume and related apparatus thereof
FR2850040B1 (fr) * 2003-01-20 2005-03-11 Centre Nat Rech Scient Systemes pour microencapsulation et leurs applications
DE602004025151D1 (de) * 2004-03-10 2010-03-04 Shimoda Biotech Pty Ltd Stabile injizierbare Diclofenac- Zubereitungen
BRPI0510119A (pt) 2004-04-23 2007-09-25 Cydex Inc formulação para dpi contendo sulfoaquil éter de ciclodextrina
SI2952197T1 (sl) 2005-10-26 2017-09-29 Cydex Pharmaceuticals, Inc. Sestavki sulfoalkil eter ciklodekstrina in metode priprave le-tega
US20070267033A1 (en) * 2006-02-09 2007-11-22 Philip Morris Usa Inc. Gamma cyclodextrin flavoring-release additives
MX2008012496A (es) * 2006-03-28 2009-01-07 Javelin Pharmaceuticals Inc Formulaciones de farmacos anti-inflamatorios no esteroidales de baja dosis y beta-ciclodextrina.
EP2522343A1 (de) * 2006-03-28 2012-11-14 Javelin Pharmaceuticals, Inc. Formulierungen aus niedrigdosiertem Diclofenac und Beta-Cyclodextrin
FR2912061A1 (fr) * 2007-02-01 2008-08-08 Aliscience Soc Par Actions Sim Complexes d'inclusion de cysteine, leur presparation et les compositions les contenant
MY166036A (en) 2011-07-20 2018-05-21 Hospira Inc Methods of treating pain
EP4653002A3 (de) 2020-03-23 2026-02-25 Czap Research And Development, LLC Orale terpencyclodextrin-einschlusskomplexvehikel
GB202105833D0 (en) * 2021-04-23 2021-06-09 Nacamed As Silicon particles for drug delivery

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5984821A (ja) * 1982-11-04 1984-05-16 Teikoku Chem Ind Corp Ltd 徐溶化組成物
IT1196033B (it) * 1984-02-22 1988-11-10 Chiesi Farma Spa Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche
US4845188A (en) * 1988-08-19 1989-07-04 Eastman Kodak Company Condensation polymers containing methine ultraviolet radiation-absorbing residues and shaped articles produced therefrom
MY106598A (en) * 1988-08-31 1995-06-30 Australian Commercial Res & Development Ltd Compositions and methods for drug delivery and chromatography.
IT1241088B (it) * 1990-03-27 1993-12-29 Chiesi Farma Spa Procedimento per la preparazione di complessi piroxicam/ciclodestrina,prodotti ottenuti e loro composizioni farmaceutiche
IT1243342B (it) * 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
EP1004318A3 (de) * 1991-06-21 2002-08-07 Takeda Chemical Industries, Ltd. Zyklodextrin-zusammensetzung
DE4200792A1 (de) * 1992-01-15 1993-07-22 Solvay Fluor & Derivate Aufarbeitung der fluorwasserstoff-phase aus reaktionsgemischen
JPH0616547A (ja) * 1992-07-01 1994-01-25 Wakamoto Pharmaceut Co Ltd 消炎点眼剤

Also Published As

Publication number Publication date
AU682887B2 (en) 1997-10-23
DE69434356D1 (de) 2005-06-09
AU7448694A (en) 1995-04-27
CA2133885A1 (en) 1995-04-09
US5674854A (en) 1997-10-07
JPH07196484A (ja) 1995-08-01
DE69434356T2 (de) 2006-05-04
KR950010910A (ko) 1995-05-15
EP0647451B1 (de) 2005-05-04
ES2240960T3 (es) 2005-10-16
CA2133885C (en) 2008-12-16
IL111184A0 (en) 1994-12-29
EP0647451A1 (de) 1995-04-12
CN1107042A (zh) 1995-08-23
CN1161115C (zh) 2004-08-11
ZA948078B (en) 1995-06-05
IL111184A (en) 2000-08-13

Similar Documents

Publication Publication Date Title
DE69434356D1 (de) Inclusion-Komplex von Beta-Cyclodextrin mit Diclofenac
ATE168373T1 (de) Benzofuranyl- und thiophenylalkancarbonsäurederivate
FI96204C (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi
KR890003720A (ko) 벤조티아졸 및 그를 유효성분으로 함유하는 항류머티스제
DK0569802T3 (da) Arylacetamider
ATE144498T1 (de) Herstellung von substituierten piperidinen
ES2105362T3 (es) Nuevos derivados de acidos quinolon- y naftiridoncarboxilicos.
ATE159713T1 (de) N-acylglutamin-derivate
ITMI931012A1 (it) Composti spiro-piranici dotati di caratteristiche fotocromatiche
DK0623620T3 (da) 5-HT3-pyrrolopyrazinderivater
ATE92070T1 (de) Azachromanderivate.
FI960588A0 (fi) Mikrobisideina käytettäviä tiokarbamoyyliyhdisteitä
DE69108580D1 (de) Optisch aktives Derivat der d-2-(6-Methoxy-2-naphthyl)-propionsäure und es enthaltende pharmazeutische Zusammensetzungen.
ES2062313T3 (es) 13-bromo- y 13,14-dibromo-ergolinas, a su preparacion y a su utilizacion en medicamentos.
KR950701617A (ko) 5-아미노-2-페녹시술폰아닐리드 화합물
ATE242227T1 (de) Tetrahydrofuranderivate
KR920000874A (ko) 내열성 수지조성물용 경화제와 그를 이용한 내열성 수지조성물

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties